Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2024-11-29 Capital/Financing Update
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
교환사채(해외교환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from the company 'Raphas' regarding the acquisition of exchangeable bonds before maturity (Put Option exercise). It details the bond series, acquisition amount, acquisition date, and the reason for the transaction. This falls under capital structure and financing updates, specifically related to debt instruments and their redemption/acquisition, which is best categorized as a Capital/Financing Update (CAP).
2024-11-29 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 라파스' (Raphas Co., Ltd.) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 1% confidence The document is a regulatory disclosure from a Korean company (Raphas) regarding a 'Derivative Trading Loss' (파생상품거래손실발생). This is a specific type of material event disclosure required by the Korea Exchange (KRX). Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory filing regarding financial impact, it is best classified as a Regulatory Filing (RNS).
2024-11-13 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity (Put Option exercise) by the company Laphas. It details the specific bond series, acquisition amount, date, and the reason for the transaction. This falls under capital structure and financing updates, specifically related to debt instruments, which is best categorized as a Capital/Financing Update (CAP).
2024-10-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Sun Bo-kyung) of the company 'Raphas'. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2024-10-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in share ownership by major shareholders and special related parties, including information on stock collateral loans and executive share changes. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-09-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.